Single and combination nonhormonal chemotherapy in breast cancer.
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use; D008593:Menopause; D008727:Methotrexate / Q000008:administration & dosage; D051379:Mice; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D002699:Chlorambucil; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D008558:Melphalan; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate